Cleavage requirements of factor V in tissue-factor induced thrombin generation

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Factor V (FV) is a critical cofactor in the coagulation cascade.
• Activation of FV by thrombin or FXa occurs at specific cleavage sites (Arg709, Arg1018, Arg1545).
• The precise role of these individual cleavage sites in thrombin generation is not fully understood.

Purpose of the Study:

• To elucidate the relative importance of FV cleavage sites (Arg709, Arg1018, Arg1545) in tissue factor-induced thrombin generation.
• To analyze the impact of mutations at these sites on FV function in plasma and purified systems.

Main Methods:

• Generated recombinant FV mutants with eliminated cleavage sites (Arg709, Arg1018, Arg1545) individually and in combination.
• Assessed clotting activity using FV-deficient plasma.
• Analyzed TF-induced thrombin generation in plasma and purified systems.

Main Results:

• Mutations at individual or all three cleavage sites did not significantly alter clotting activity in standard assays.
• Differences in thrombin generation were observed primarily at lower tissue factor concentrations.
• Arg709 and Arg1545 mutations prolonged lag phase; Arg1545 also decreased max thrombin activity.
• Triple mutant FV exhibited prolonged lag phase and reduced propagation phase thrombin generation.
• Purified systems confirmed the importance of all three sites for robust thrombin generation.

Conclusions:

• Cleavage sites on FV are not essential for initial FXa-FV complex formation and low prothrombinase activity.
• All three cleavage sites (Arg709, Arg1018, Arg1545) play distinct but vital roles in generating highly active Factor Va (FVa).
• These sites are crucial for efficient FXa-mediated prothrombin activation, particularly under conditions of limited TF initiation.